News twelve

Fidia Pharma USA Inc to exhibit at ACR/ARHP Annual Meeting 2012

Fidia Pharma USA Inc will be exhibiting at the Annual Meeting of the American College of Rheumatology (ACR) in Washington, D.C., November 9-14, 2012. Please come and see us at booth 641.

We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee.

HYALGAN® is a treatment option for people who do not get adequate pain relief from simple painkillers (like Tylenol® or Advil®) or from exercise and physical therapy. HYALGAN® injections can be used in addition to prescription pain relievers (like Celebrex®).

Our Four Leading Principles: